Vertex Pharma upgraded at Canaccord Genuity after Q4 results
Vertex Pharmaceuticals (VRTX) stock gets an upgrade from Canaccord Genuity after its Q4 2024 results on Tuesday, Read more here.
Le Lézard8h
DIA 2025 Global Annual Meeting Highlights Need for Neutral Collaborations to Advance Innovations in Biomedical Science and Healthcare
DIA, a global multidisciplinary life sciences membership association, will bring together thousands of stakeholders from all over the world to address opportunities for collaboration in medical ...
Reuters on MSN17h
German TeamViewer posts mid-term targets after completing 1E acquisition
(Reuters) - German software developer TeamViewer posted on Wednesday mid-term revenue growth targets after it closed its ...